fda glp 1 compounding The FDA recently published updates clarifying policies for compounding drug manufacturers producing Hims & Hers stock falls
Description
The OOS investigation process (no corrective actions for failure to notify patients) The root cause of sterility and potency failures (not identified or discussed in the firms responses)

Lets build on what we have learned and accept that both drusg fell a little short of a clinically meaningful difference

A 2025 meta-analysis in Scientific Reports found that GLP-1 receptor agonists reduced body weight, BMI, and insulin resistance in women with PCOS, although nausea, vomiting, and dizziness were more common

Act 4: The Grand Appetite Suppression Finale For the grand finale, we have the uproarious appetite suppression showstopper
